The system gives your team the agility to develop immunoassays more quickly and increase data quality with reduced hands-on time, reliably and precisely in every phase of biotherapeutic product development
Pharmacokinetics/Toxicokinetics
“Better Science – fewer animals” Nanoliter-scale assays reduce animal usage in preclinical studies 
Pharmacodynamics & Biomarker Monitoring
Extract maximum biomarker/PD information from limited sample volumes
Immunogenicity
Automated sample pretreatment and immunoassay workflow at nanoliter-scale reduces hands-on time
Affinity
Design and evaluate in solution affinity runs using non-modified substances
Product Titer Quantitation
Broad dynamic range ensures high-sensitivity quantification throughout the development process
Impurities for downstream purification
Rapid quantification of contaminants enables data-driven decisions to be made throughout the biotherapeutics workflow
Get in touch
